Literature DB >> 21255746

Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States.

Walter A Rocca1, Ronald C Petersen, David S Knopman, Liesi E Hebert, Denis A Evans, Kathleen S Hall, Sujuan Gao, Frederick W Unverzagt, Kenneth M Langa, Eric B Larson, Lon R White.   

Abstract

Declines in heart disease and stroke mortality rates are conventionally attributed to reductions in cigarette smoking, recognition and treatment of hypertension and diabetes, effective medications to improve serum lipid levels and to reduce clot formation, and general lifestyle improvements. Recent evidence implicates these and other cerebrovascular factors in the development of a substantial proportion of dementia cases. Analyses were undertaken to determine whether corresponding declines in age-specific prevalence and incidence rates for dementia and cognitive impairment have occurred in recent years. Data spanning 1 or 2 decades were examined from community-based epidemiological studies in Minnesota, Illinois, and Indiana, and from the Health and Retirement Study, which is a national survey. Although some decline was observed in the Minnesota cohort, no statistically significant trends were apparent in the community studies. A significant reduction in cognitive impairment measured by neuropsychological testing was identified in the national survey. Cautious optimism appears justified. Copyright Â
© 2011 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21255746      PMCID: PMC3026476          DOI: 10.1016/j.jalz.2010.11.002

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  40 in total

Review 1.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

2.  National estimates of the quantity and cost of informal caregiving for the elderly with dementia.

Authors:  K M Langa; M E Chernew; M U Kabeto; A R Herzog; M B Ofstedal; R J Willis; R B Wallace; L M Mucha; W L Straus; A M Fendrick
Journal:  J Gen Intern Med       Date:  2001-11       Impact factor: 5.128

3.  Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans.

Authors:  H C Hendrie; B O Osuntokun; K S Hall; A O Ogunniyi; S L Hui; F W Unverzagt; O Gureje; C A Rodenberg; O Baiyewu; B S Musick
Journal:  Am J Psychiatry       Date:  1995-10       Impact factor: 18.112

4.  Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn.

Authors:  Steven D Edland; Walter A Rocca; Ronald C Petersen; Ruth H Cha; Emre Kokmen
Journal:  Arch Neurol       Date:  2002-10

5.  An estimate of the worldwide prevalence and direct costs of dementia in 2003.

Authors:  A Wimo; L Jonsson; B Winblad
Journal:  Dement Geriatr Cogn Disord       Date:  2006-01-09       Impact factor: 2.959

6.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

Review 7.  An active and socially integrated lifestyle in late life might protect against dementia.

Authors:  Laura Fratiglioni; Stephanie Paillard-Borg; Bengt Winblad
Journal:  Lancet Neurol       Date:  2004-06       Impact factor: 44.182

8.  Incidence and causes of nondegenerative nonvascular dementia: a population-based study.

Authors:  David S Knopman; Ronald C Petersen; Ruth H Cha; Steven D Edland; Walter A Rocca
Journal:  Arch Neurol       Date:  2006-02

9.  The neuropathology of older persons with and without dementia from community versus clinic cohorts.

Authors:  Julie A Schneider; Neelum T Aggarwal; Lisa Barnes; Patricia Boyle; David A Bennett
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989.

Authors:  R D Brown; J P Whisnant; J D Sicks; W M O'Fallon; D O Wiebers
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

View more
  174 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 2.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

3.  Cohort effects in age-associated cognitive trajectories.

Authors:  Hiroko H Dodge; Jian Zhu; Ching-Wen Lee; Chung-Chou Ho Chang; Mary Ganguli
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-23       Impact factor: 6.053

Review 4.  Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Authors:  Peter T Nelson; Elizabeth Head; Frederick A Schmitt; Paulina R Davis; Janna H Neltner; Gregory A Jicha; Erin L Abner; Charles D Smith; Linda J Van Eldik; Richard J Kryscio; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-04-24       Impact factor: 17.088

5.  Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.

Authors:  Lewis H Kuller; Oscar L Lopez
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

Review 6.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

7.  Loss in efficacy measures of tolfenamic acid in a tau knock-out model: Relevance to Alzheimer's disease.

Authors:  Allison Leso; Syed W Bihaqi; Anwar Masoud; Joanna K Chang; Asma Lahouel; Nasser Zawia
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-26

8.  Incidence of Dementia and Alzheimer Disease Over Time: A Meta-Analysis.

Authors:  Sujuan Gao; Heather N Burney; Chris M Callahan; Christianna E Purnell; Hugh C Hendrie
Journal:  J Am Geriatr Soc       Date:  2019-06-20       Impact factor: 5.562

Review 9.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

Review 10.  Proton MRS in mild cognitive impairment.

Authors:  Kejal Kantarci
Journal:  J Magn Reson Imaging       Date:  2013-04       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.